|
|
|
Insider
Information: |
Hopkinson Craig C. |
Relationship: |
Director |
City: |
Waltham |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
120,204 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$3,444,148 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
120,204 |
|
|
Total
Value |
$3,444,148 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Alkermes Plc |
ALKS |
EVP R&D, Chief Medical... |
2024-02-23 |
109,709 |
2018-06-07 |
0 |
Premium* |
|
Albireo Pharma Inc |
ALBO |
Director |
2022-12-01 |
10,495 |
2022-12-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
56 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ALKS |
Alkermes Plc |
EVP R&D, Chief Medical Officer |
|
2021-04-15 |
4 |
AS |
$19.72 |
$570,288 |
D/D |
(28,920) |
0 |
0 |
- |
|
ALKS |
Alkermes Plc |
EVP R&D, Chief Medical Officer |
|
2021-06-09 |
4 |
AS |
$24.60 |
$21,697 |
D/D |
(882) |
0 |
0 |
- |
|
ALKS |
Alkermes Plc |
SVP, Med Dev/Med Affairs, CMO |
|
2018-06-07 |
4 |
D |
$48.30 |
$17,823 |
D/D |
(369) |
881 |
0 |
- |
|
ALKS |
Alkermes Plc |
EVP R&D, Chief Medical Officer |
|
2021-06-07 |
4 |
D |
$23.50 |
$8,648 |
D/D |
(368) |
882 |
0 |
- |
|
ALKS |
Alkermes Plc |
SVP, Med Dev/Med Affairs, CMO |
|
2018-06-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,250 |
1,250 |
0 |
- |
|
ALKS |
Alkermes Plc |
EVP R&D, Chief Medical Officer |
|
2021-06-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,250 |
1,250 |
0 |
- |
|
ALKS |
Alkermes Plc |
SVP, Med Dev/Med Affairs, CMO |
|
2018-12-07 |
4 |
D |
$34.01 |
$40,064 |
D/D |
(1,178) |
3,703 |
0 |
- |
|
ALKS |
Alkermes Plc |
SVP, Med Dev/Med Affairs, CMO |
|
2018-12-07 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
4,881 |
0 |
- |
|
ALKS |
Alkermes Plc |
SVP, Med Dev/Med Affairs, CMO |
|
2019-02-16 |
4 |
D |
$32.54 |
$35,241 |
D/D |
(1,083) |
5,995 |
0 |
- |
|
ALKS |
Alkermes Plc |
SVP, Med Dev/Med Affairs, CMO |
|
2019-06-07 |
4 |
D |
$22.83 |
$8,401 |
D/D |
(368) |
6,877 |
0 |
- |
|
ALKS |
Alkermes Plc |
SVP, Med Dev/Med Affairs, CMO |
|
2019-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,375 |
7,078 |
0 |
- |
|
ALKS |
Alkermes Plc |
SVP, Med Dev/Med Affairs, CMO |
|
2019-06-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,250 |
7,245 |
0 |
- |
|
ALKS |
Alkermes Plc |
EVP R&D, Chief Medical Officer |
|
2020-02-16 |
4 |
D |
$17.77 |
$20,826 |
D/D |
(1,172) |
9,080 |
0 |
- |
|
ALKS |
Alkermes Plc |
EVP R&D, Chief Medical Officer |
|
2021-09-14 |
4 |
D |
$30.60 |
$172,798 |
D/D |
(5,647) |
9,496 |
0 |
- |
|
ALKS |
Alkermes Plc |
EVP R&D, Chief Medical Officer |
|
2022-02-18 |
4 |
AS |
$25.17 |
$58,042 |
D/D |
(2,306) |
9,496 |
0 |
- |
|
ALKS |
Alkermes Plc |
EVP R&D, Chief Medical Officer |
|
2020-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,375 |
10,252 |
0 |
- |
|
ALBO |
Albireo Pharma Inc |
Director |
|
2022-12-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,495 |
10,495 |
0 |
- |
|
ALKS |
Alkermes Plc |
EVP R&D, Chief Medical Officer |
|
2022-02-16 |
4 |
D |
$26.79 |
$28,639 |
D/D |
(1,069) |
11,802 |
0 |
- |
|
ALKS |
Alkermes Plc |
EVP R&D, Chief Medical Officer |
|
2022-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,375 |
12,871 |
0 |
- |
|
ALKS |
Alkermes Plc |
EVP R&D, Chief Medical Officer |
|
2020-02-21 |
4 |
D |
$20.24 |
$40,561 |
D/D |
(2,004) |
13,951 |
0 |
- |
|
ALKS |
Alkermes Plc |
EVP R&D, Chief Medical Officer |
|
2020-06-07 |
4 |
D |
$17.19 |
$6,326 |
D/D |
(368) |
14,833 |
0 |
- |
|
ALKS |
Alkermes Plc |
EVP R&D, Chief Medical Officer |
|
2021-09-14 |
4 |
A |
$0.00 |
$0 |
D/D |
15,143 |
15,143 |
0 |
- |
|
ALKS |
Alkermes Plc |
EVP R&D, Chief Medical Officer |
|
2020-06-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,250 |
15,201 |
0 |
- |
|
ALKS |
Alkermes Plc |
EVP R&D, Chief Medical Officer |
|
2020-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,875 |
15,955 |
0 |
- |
|
ALKS |
Alkermes Plc |
EVP R&D, Chief Medical Officer |
|
2022-02-20 |
4 |
D |
$25.08 |
$74,387 |
D/D |
(2,966) |
16,626 |
0 |
- |
|
56 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|